Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Susceptibility of paramyxoviruses and filoviruses to inhibition by 2′-monofluoro- and 2′-difluoro-4′-azidocytidine analogs
  • Published Date:
    Mar 27 2018
  • Source:
    Antiviral Res. 153:101-113.
  • Language:
    English
Filetype[PDF-1.90 MB]


Details:
  • Alternative Title:
    Antiviral Res
  • Personal Author:
  • Description:
    Ebolaviruses, marburgviruses, and henipaviruses are zoonotic pathogens belonging to the Filoviridae and Paramyxoviridae families. They exemplify viruses that continue to spill over into the human population, causing outbreaks characterized by high mortality and significant clinical sequelae in survivors of infection. There are currently no approved small molecule therapeutics for use in humans against these viruses. In this study, we evaluated the antiviral activity of the nucleoside analog 4'-azidocytidine (4'N|-C, R1479) and its 2'-monofluoro- and 2'-difluoro-modified analogs (2'F-4'N|-C and 2'diF-4'N|-C) against representative paramyxoviruses (Nipah virus, Hendra virus, measles virus, and human parainfluenza virus 3) and filoviruses (Ebola virus, Sudan virus, and Ravn virus). We observed enhanced antiviral activity against paramyxoviruses with both 2'diF-4'N|-C and 2'F-4'N|-C compared to R1479. On the other hand, while R1479 and 2'diF-4'N|-C inhibited filoviruses similarly to paramyxoviruses, we observed 10-fold lower filovirus inhibition by 2'F-4'N|-C. To our knowledge, this is the first study to compare the susceptibility of paramyxoviruses and filoviruses to R1479 and its 2'-fluoro-modified analogs. The activity of these compounds against negative-strand RNA viruses endorses the development of 4'-modified nucleoside analogs as broad-spectrum therapeutics against zoonotic viruses of public health importance.

  • Subject:
  • Pubmed ID:
    29601894
  • Pubmed Central ID:
    PMC6066796
  • Document Type:
    Journal Article
  • Funding:
    CC999999/Intramural CDC HHS/United States
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
No Related Documents.
You May Also Like:
  1. 4′-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency
    Personal Author:
    Hotard, Anne L.; He, Biao; Nichol, Stuart T.; Spiropoulou, Christina F.; Lo, Michael K.;
    Published Date:
    Jun 17 2017
    Source:
    Antiviral Res. 144:147-152.
    Description:
    The henipaviruses Nipah virus and Hendra virus are highly pathogenic zoonotic paramyxoviruses which have caused fatal outbreaks of encephalitis and respiratory disease in humans. Despite the availability of a licensed equine Hendra virus vaccine and ...
    File Type:
    Filetype[PDF - 769.63 KB]
  2. Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase
    Personal Author:
    Jordan, Paul C.; Liu, Cheng; Raynaud, Pauline; Lo, Michael K.; Spiropoulou, Christina F.; Symons, Julian A.; Beigelman, Leo; Deval, Jerome;
    Published Date:
    Feb 09 2018
    Source:
    PLoS Pathog. 14(2).
    Description:
    Paramyxoviruses represent a family of RNA viruses causing significant human diseases. These include measles virus, the most infectious virus ever reported, in addition to parainfluenza virus, and other emerging viruses. Paramyxoviruses likely share c...
    File Type:
    Filetype[PDF - 8.33 MB]
  3. Potential Use of Antiviral Agents in Polio Eradication
    Personal Author:
    De Palma, Armando M.; Pürstinger, Gerhard; Wimmer, Eva; Patick, Amy K.; Andries, Koen; Rombaut, Bart; De Clercq, Erik; Neyts, Johan;
    Published Date:
    Apr 2008
    Source:
    Emerg Infect Dis. 14(4):545-551.
    Description:
    In 1988, the World Health Assembly launched the Global Polio Eradication Initiative, which aimed to use large-scale vaccination with the oral vaccine to eradicate polio worldwide by the year 2000. Although important progress has been made, polio rema...
    File Type:
    Filetype[PDF - 226.51 KB]
  4. Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compounds
    Personal Author:
    Welch, Stephen R.; Chakrabarti, Ayan K.; Wiggleton Guerrero, Lisa; Jenks, Harley M.; Lo, Michael K.; Nichol, Stuart T.; Spiropoulou, Christina F.; Albariño, César G.;
    Published Date:
    Mar 09 2018
    Source:
    PLoS Negl Trop Dis. 12(3).
    Description:
    Sosuga virus (SOSV) is a recently discovered zoonotic paramyxovirus isolated from a single human case in 2012; it has been ecologically and epidemiologically associated with transmission by the Egyptian rousette bat (Rousettus aegyptiacus). Bats have...
    File Type:
    Filetype[PDF - 12.85 MB]
  5. Assessment of Potential Zoonotic Disease Exposure and Illness Related to an Annual Bat Festival — Idanre, Nigeria
    Personal Author:
    Vora, Neil M.; Osinubi, Modupe; Wallace, Ryan M.; Aman-Oloniyo, Abimbola; Gbadegesin, Yemi H.; Sebastian, Yennan Kerecvel; Saliman, Olugbon Abdullateef; Niezgoda, Mike; Davis, Lora; Recuenco, Sergio;
    Published Date:
    Apr 18 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(15):334.
    Description:
    Bats provide vital ecologic services that humans benefit from, such as seed dispersal and pest control, and are a food source for some human populations. However, bats also are reservoirs for a number of high-consequence zoonoses, including paramyxov...
    File Type:
    Filetype[PDF - 92.44 KB]